[page 39↓]

REFERENCES

Agarwal, S. K., S. C. Guru, et al. (1999). “Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription.” Cell 96 (1): 143-52.

Agarwal, S. K., M. Kester, et al. (1997). “Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states.” Hum Mol Genet 6: 1169-75.

Antalis, T. M., J. A. Reeder, et al. (1998). “Down-regulation of the down-regulated in adenoma (DRA) gene correlates with colon tumor progression.” Clin Cancer Res 4 (8): 1857-63.

Anthony, P. P. and R. A. Drury (1970). “Elastic vascular sclerosis of mesenteric blood vessels in argentaffin carcinoma.” J Clin Pathol 23 (2): 110-8.

Aoki, A., T. Tsukada, et al. (1997). “Multiple endocrine neoplasia type 1 presented with manic-depressive disorder: a case report with an identified MEN1 gene mutation.” Jpn J Clin Oncol 27: 419-22.

Arber, N., A. I. Neugut, et al. (1997). “Molecular genetics of small bowel cancer.” Cancer Epidemiol Biomarkers Prev 6 (9): 745-8.

Bakker, W. H., R. Albert, et al. (1991). “[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation.” Life Sci 49 (22): 1583-91.

Bartsch, D., S. A. Hahn, et al. (1999). “Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors.” Oncogene 18 (14): 2367-71.

Basset, J. H., S. A. Forbes, et al. (1998). “Characterization of mutations in patients with multiple endocrine neoplasia type 1.” Am J Hum Genet 62: 232-44.

Benachenhou, N., S. Guiral, et al. (1998). “High resolution deletion mapping reveals frequent allelic losses at the DNA mismatch repair loci hMLH1 and hMSH3 in non-small cell lung cancer.” Int J Cancer 77 (2): 173-80.

Blanquet, V., F. Garreau, et al. (1988). “Regional mapping to 4q32.1 by in situ hybridization of a DNA domain rearranged in human liver cancer.” Hum Genet 80 (3): 274-6.

Bold, R. J., J. Ishizuka, et al. (1995). “Nerve growth factor as a mitogen for a pancreatic carcinoid cell line.” J Neurochem 64 (6): 2622-8.

Bos, J. L., E. R. Fearon, et al. (1987). “Prevalence of ras gene mutations in human colorectal cancers.” Nature 327 (6120): 293-7.

Brunsson, I., J. Fahrenkrug, et al. (1990). “On the role of vasoactive intestinal polypeptide and tachykinins in the secretory reflex elicited by chemical peritonitis in the cat small intestine.” Acta Physiol Scand 139 (1): 63-75.

Bystrom, C., C. Larsson, et al. (1990). “Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors.” Proc Natl Acad Sci U S A 87 (5): 1968-72.

Calender, A. (1998). “Genetic testing in multiple endocrine neoplasia and related syndromes.” Forum (Genova) 8 (2): 146-59.

Carson, D. A. and A. Lois (1995). “Cancer progression and p53.” Lancet 346 (8981): 1009-11.


[page 40↓]

Cavenee, W. K., T. P. Dryja, et al. (1983). “Expression of recessive alleles by chromosomal mechanisms in retinoblastoma.” Nature 305 (5937): 779-84.

Cavenee, W. K., M. F. Hansen, et al. (1985). “Genetic origin of mutations predisposing to retinoblastoma.” Science 228 (4698): 501-3.

Chandrasekharappa, S. C., S. C. Guru, et al. (1997). “Positional cloning of the gene for multiple endocrine neoplasia-type 1.” Science 276 (5311): 404-7.

Chaudhry, A., K. Oberg, et al. (1994). “Expression of transforming growth factors beta 1, beta 2, beta 3 in neuroendocrine tumors of the digestive system.” Anticancer Res 14: 2085-91.

Chaudhry, A., V. Papanicolaou, et al. (1992). “Expression of platelet-derived growth factor and its receptors in neuroendocrine tumors of the digestive system.” Cancer Res 52: 1006-12.

Chu, G. and L. Mayne (1996). “Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy: do the genes explain the diseases?” Trends Genet 12 (5): 187-92.

Chung, D. C., S. B. Brown, et al. (1998). “Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors.” Cancer Res 58 (16): 3706-11.

D´Adda, T., S. Pizzi, et al. (2002). “Different Patterns of 11q Allelic losses in Digestive Endocrine Tumors.” Human Pathology 33 (3): 322-329.

Davis, Z., C. G. Moertel, et al. (1973). “The malignant carcinoid syndrome.” Surg Gynecol Obstet 137 (4): 637-44.

Debas, H. T. and S. J. Mulvihill (1994). “Neuroendocrine gut neoplasms. Important lessons from uncommon tumors.” Arch Surg 129 (9): 965-71; discussion 971-2.

Debelenko, L. V., M. R. Emmert-Buck, et al. (1997a). “The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids.” Gastroenterology 113 (3): 773-81.

DeLellis, R. A. (1995). “Multiple endocrine neoplasia syndromes revisited. Clinical, morphologic, and molecular features.” Lab Invest 72 (5): 494-505.

Eckhauser, F. E., L. C. Argenta, et al. (1981). “Mesenteric angiopathy, intestinal gangrene, and midgut carcinoids.” Surgery 90 (4): 720-8.

Eppert, K., S. W. Scherer, et al. (1996). “MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma.” Cell 86 (4): 543-52.

Eriksson, B., H. Arnberg, et al. (1990). “Neuroendocrine pancreatic tumours:Clinical presentation, biochemical and histopathological findings in 84 patients.” J Intern Med 228 (2): 103-13.

Eriksson, B., E. Larsson, et al. (1989). “Neuroendocrine pancreatic tumors.Clinical findings in a prospective study of 84 patients.” Acta Oncol 28: 373-7.

Eriksson, B., E. Larsson, et al. (1998). “Liver embolization of patients with malignant neuroendocrine gastrointestinal tumors.” Cancer 83: 2293-301.

Eshleman, J. R. and S. D. Markowitz (1996). “Mismatch repair defects in human carcinogenesis.” Hum Mol Genet 5 (Spec No): 1489-94.


[page 41↓]

Farid, N. R., S. Buehler, et al. (1980). “Prolactinomas in familial multiple endocrine neoplasia syndrome type I. Relationship to HLA and carcinoid tumors.” Am J Med 69 (6): 874-80.

Fearon, E. R., K. R. Cho, et al. (1990). “Identification of a chromosome 18q gene that is altered in colorectal cancers.” Science 247 (4938): 49-56.

Fearon, E. R., B. C. Ekstrand, et al. (1994). “Studies of the deleted in colorectal cancer gene in normal and neoplastic tissues.” Cold Spring Harb Symp Quant Biol 59: 637-43.

Feldman, J. M. (1989). “Carcinoid tumors and the carcinoid syndrome.” Curr Probl Surg 26 (12): 835-85.

Feldman, J. M. and T. M. O'Dorisio (1986). “Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors.” Am J Med 81 (6B): 41-8.

Fishel, R. (1998). “Mismatch repair, molecular switches, and signal transduction.” Genes Dev 12 (14): 2096-101.

Fishel, R. and R. D. Kolodner (1995). “Identification of mismatch repair genes and their role in the development of cancer.” Curr Opin Genet Dev 5 (3): 382-95.

Ford, J. M. and P. C. Hanawalt (1997). “Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts.” J Biol Chem 272 (44): 28073-80.

Friedl, W., R. Kruse, et al. (1999). “Frequent 4-bp deletion in exon 9 of the SMAD4/MADH4 gene in familial juvenile polyposis patients.” Genes Chromosomes Cancer 25 (4): 403-6.

Friedman, E., K. Sakaguchi, et al. (1989). “Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1.” N Engl J Med 321: 213-8.

Funa, K., V. Papanicolaou, et al. (1990). “Expression of platelet-derived growth factor beta-receptors on stromal tissue cells in human carcinoid tumors.” Cancer Res 50 (3): 748-53.

Gartel, A. L., M. S. Serfas, et al. (1996). “p21--negative regulator of the cell cycle.” Proc Soc Exp Biol Med 213 (2): 138-49.

Ghimenti, C., A. Lonobile, et al. (1999). “Microsatellite instability and allelic losses in neuroendocrine tumors of the gastro-entero-pancreatic system.” Int J Oncol 15 (2): 361-6.

Gobl, A. E., M. Berg, et al. (1999). “Menin represses JunD-activated transcription by a histone deacetylase- dependent mechanism.” Biochim Biophys Acta 1447 (1): 51-6.

Godwin, J. D. d. (1975). “Carcinoid tumors. An analysis of 2,837 cases.” Cancer 36 (2): 560-9.

Gortz, B., J. Roth, et al. (1999). “Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms.” Am J Pathol 154 (2): 429-36.

Granberg, D., E. Wilander, et al. (2000). “Prognostic markers in patients with typical bronchial carcinoid tumors.” J Clin Endocrinol Metab 85: 3425-3430.

Greenberg, R. S., D. A. Baumgarten, et al. (1987). “Prognostic factors for gastrointestinal and bronchopulmonary carcinoid tumors.” Cancer 60 (10): 2476-83.

Grimelius, L. and E. Wilander (1980). “Silver stains in the study of endocrine cells of the gut and pancreas.” Invest Cell Pathol 3 (1): 3-12.


[page 42↓]

Guo, Z., Q. Li, et al. (2000). “Clonality analysis of multifocal carcinoid tumours of the small intestine by X-chromosome inactivation analysis.” J Pathol 190 (1): 76-9.

Heppner, C., M. Reincke, et al. (1999). “MEN1 gene analysis in sporadic adrenocortical neoplasms.” J Clin Endocrinol Metab 84 (1): 216-9.

Hessman, O., D. Lindberg, et al. (1999). “Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1- associated pancreatic endocrine tumors.” Genes Chromosomes Cancer 26 (3): 258-64.

Hessman, O., D. Lindberg, et al. (1998). “Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumors of the endocrine pancreas.” Cancer Res 58 (3): 377-9.

Hibi, K., T. Takahashi, et al. (1992). “Three distinct regions involved in 3p deletion in human lung cancer.” Oncogene 7 (3): 445-9.

Hilgers, W., J. J. Song, et al. (2000). “Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.” Genes Chromosomes Cancer 27 (4): 353-7.

Howe, J. R., S. Roth, et al. (1998). “Mutations in the Smad4/DPC4 gene in juvenile polyposis.” Science May 280: 1086-8.

Huang, S. C., Z. Zhuang, et al. (1999). “Nuclear/cytoplasmic localization of the multiple endocrine neoplasia type 1 gene product, menin.” Lab Invest 79 (3): 301-10.

Imam, H., B. Eriksson, et al. (1997). “Induction of apoptosis in neuroendocrine tumors of the digestive system during treatment with somatostatin anlogues.” Acta Oncol 36: 607-14.

Jakobovitz, O., D. Nass, et al. (1996). “Carcinoid tumors frequently display genetic abnormalities involving chromosome 11 [see comments].” J Clin Endocrinol Metab 81 (9): 3164-7.

Janson, E. T., L. Holmberg, et al. (1997). “Carcinoid tumors:analysis of prognostic factors and survival in 301 patients from a referral center.” Ann Oncol 8: 685-90.

July, L. V., K. A. Northcott, et al. (1999). “Coexisting carcinoid tumors in familial adenomatous polyposis- associated upper intestinal adenomas.” Am J Gastroenterol 94 (4): 1091-4.

Kinzler, K. W., M. C. Nilbert, et al. (1991). “Identification of FAP locus genes from chromosome 5q21.” Science 253 (5020): 661-5.

Kjellman, M., L. Roshani, et al. (1999). “Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16.” J Clin Endocrinol Metab 84 (2): 730-5.

Kloppel, G., E. Solcia, et al. (1999). “Classification of neuroendocrine tumours.” Ital J Gastroenterol Hepatol 31 (Suppl 2): S 111-6.

Knudson, A. G., Jr. (1978). “Retinoblastoma: a prototypic hereditary neoplasm.” Semin Oncol 5 (1): 57-60.

Knudson, A. G., Jr., N. Di Ferrante, et al. (1971). “Effect of leukocyte transfusion in a child with type II mucopolysaccharidosis.” Proc Natl Acad Sci U S A 68 (8): 1738-41.

Kolodner, R. (1996). “Biochemistry and genetics of eukaryotic mismatch repair.” Genes Dev 10 (12): 1433-42.


[page 43↓]

Kong, X. T., S. H. Choi, et al. (1997). “Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.” Cancer Res 57 (17): 3772-8.

Krejs, G. J., L. Orci, et al. (1979). “Somatostatinoma syndrome. Biochemical, morphologic and clinical features.” N Engl J Med 301 (6): 285-92.

Kytola, S., B. Nord, et al. (2002). “Alterations of the SDHD gene locus in midgut carcinoids, Merkel cell carcinomas, pheochromocytomas, and abdominal paragangliomas.” Genes Chromosomes Cancer 34 (3): 325-332.

La Rosa, S., F. Sessa, et al. (1996). “Prognostic criteria in non functioning pancreatic endocrine tumours.” Virchow Arch 429: 323-333.

Lambert, W. C., H. R. Kuo, et al. (1995). “Xeroderma pigmentosum.” Dermatol Clin 13 (1): 169-209.

Lamberts, R. and M. Gregor (1999). “Multiple endocrine neoplasia Type I. Diagnosis and therapy in a case with classical family history (published erratum appears in Med Klin 1999 Sep 15;94(9):521).” Med Klin 94 (8): 447-52.

Larsson, C., B. Skogseid, et al. (1988). “Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma.” Nature 332 (6159): 85-7.

Ledgerwood, E. C., J. S. Pober, et al. (1999). “Recent advances in the molecular basis of TNF signal transduction.” Lab Invest 79 (9): 1041-50.

Lembeck, F. (1953). “5-Hydroxytryptamine in a carcinoid tumor.” Nature 172: 910-11.

Lemmens, I., W. J. Van de Ven, et al. (1997). “Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1.” Hum Mol Genet 6 (7): 1177-83.

Liu, B., R. E. Parsons, et al. (1994). “hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds.” Cancer Res 54 (17): 4590-4.

Lucas, K. J. and J. M. Feldman (1986). “Flushing in the carcinoid syndrome and plasma kallikrein.” Cancer 58 (10): 2290-3.

Lundin, L. (1991). “Carcinoid heart disease. A cardiologist's viewpoint.” Acta Oncol 30 (4): 499-502.

Makridis, C., A. Ekbom, et al. (1997). “Survival and daily physical activity in patients treated for advanced midgut carcinoid tumors.” Surgery 122 (6): 1075-82.

Makridis, C., J. Rastad, et al. (1996). “Progression of metastases and symptom improvement from laparotomy in midgut carcinoid tumors.” World J Surg 20 (7): 900-6; discussion 907.

Mallette, L. E. (1994). “Management of hyperparathyroidism in the multiple endocrine neoplasia syndromes and other familial endocrinopathies.” Endocrinol Metab Clin North Am 23 (1): 19-36.

Mani, S., I. M. Modlin, et al. (1994). “Carcinoids of the rectum.” J Am Coll Surg 179 (2): 231-48.

Marshall, C. J. (1991). “Tumor suppressor genes.” Cell 64 (2): 313-26.

Martin, S. J. and D. R. Green (1995). “Protease activation during apoptosis: death by a thousand cuts?” Cell 82 (3): 349-52.


[page 44↓]

Marx, S. J., S. K. Agarwal, et al. (1998). “Germline and somatic mutation of the gene for multiple endocrine neoplasia type 1 (MEN1).” J Intern Med 243 (6): 447-53.

Marx, S. J., S. K. Agarwal, et al. (1999).Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.” Recent Prog Horm Res 54: 397-438.

Mayr, B., S. Apenberg, et al. (1997). “Menin mutations in patients with multiple endocrine neoplasia type 1.” Eur J Endocrinol 137: 684-7.

McCutcheon, I. E. (1994). “Management of individual tumor syndromes. Pituitary neoplasia.” Endocrinol Metab Clin North Am 23 (1): 37-51.

McDermott, E. W., B. Guduric, et al. (1994). “Prognostic variables in patients with gastrointestinal carcinoid tumours.” Br J Surg 81 (7): 1007-9.

Metz, D. C. (1995). “Multiple endocrine neoplasia type I.” Semin Gastrointest Dis 6 (2): 56-66.

Moertel, C., W. Sauer, et al. (1961). “Life history of the carcinoid tumor of the small intestine.” Cancer 14: 901-12.

Moertel, C. G. (1987). “Karnofsky memorial lecture. An odyssey in the land of small tumors.” J Clin Oncol 5 (10): 1502-22.

Moesta, K. T. and P. Schlag (1990). “Proposal for a new carcinoid tumour staging system based on tumour tissue infiltration and primary metastasis; a prospective multicentre carcinoid tumour evaluation study. West German Surgical Oncologists' Group.” Eur J Surg Oncol 16 (4): 280-8.

Nilsson, O., B. Wangberg, et al. (1995). “Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours.” Int J Cancer 60 (5): 645-51.

Nilsson, O., B. Wangberg, et al. (1993). “Growth factors and carcinoid tumors.” Acta Oncol 32: 115-24.

Nord, B., C. Larsson, et al. (1999). “Sporadic follicular thyroid tumors show loss of a 200-kb region in 11q13 without evidence for mutations in the MEN1 gene.” Genes Chromosomes Cancer 26 (1): 35-9.

Norheim, I., E. Theodorsson-Norheim, et al. (1986). “Tachykinins in carcinoid tumors: their use as a tumor marker and possible role in the carcinoid flush.” J Clin Endocrinol Metab 63 (3): 605-12.

Oberg, K. (1996). “Neuroendocrine gastrointestinal tumours.” Ann Oncol 7 (5): 453-63.

Oberg, K., B. Eriksson, et al. (1994). “Interferones alone or in combination with chemotherapy ot other biologicals in the treatment of neuroendocrine gut and pancreatic tumors.” Digestion 55: 64-9.

Oberg, K., I. Norheim, et al. (1989). “Treatment of malignant carcinoid tumors:a randomized controlled study of streptozocin plus 5-FU and human leucocyte interferone.” Eur J Cancer Clin Oncol 25 :1475-1479.

Olufemi, S. E., J. S. Green, et al. (1998). “Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1Burin) in four kindreds from Newfoundland.” Hum Mutat 11: 264-9.

Panariello, L., M. I. Scarano, et al. (1998). “hMLH1 mutations in hereditary nonpolyposis colorectal cancer kindreds. Mutations in brief no. 182. Online.” Hum Mutat 12 (3): 216-7.


[page 45↓]

Papadimitrakopoulou, V. A., Y. Oh, et al. (1998). “Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer.” Clin Cancer Res 4 (3): 539-44.

Pearse, A. G. (1974). “The APUD cell concept and its implications in pathology.” Pathol Annu 9 (0): 27-41.

Pearson, C. and P. Fitzgerald (1949). “Carcinoid tumors - a re-emphasis of their malignant nature. Review of 140 cases.” Cancer 2: 1005-26.

Pelosi, G., E. Bresaola, et al. (1996). “Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: a comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables.” Hum Pathol 27 (11): 1124-34.

Pipeleers-Marichal, M., C. Donow, et al. (1993). “Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I.” World J Surg 17 (4): 481-8.

Plöckinger, U. and B. Wiedenmann (2000). Systemic therapy for metastatic or residual extrapancreatic neuroendocrine tumors. Philadelphia, Lippincott, Williams and Wilkins.

Ramnani, D. M., Wistuba, II, et al. (1999). “K-ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix.” Cancer 86 (1): 14-21.

Regoli, D. and F. Nantel (1991). “Pharmacology of neurokinin receptors.” Biopolymers 31 (6): 777-83.

Reubi, J. C., L. K. Kvols, et al. (1990). “Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.” Cancer Res 50 (18): 5969-77.

Rindi, G., C. Bordi, et al. (1996). “Gastric carcinoids and Neuroendocrine Carcinomas: Pathogenesis, Pathology, and Behaviour.” World J Surg 20: 168-172.

Rindi, G., C. Capella, et al. (2000). “Introduction to a revised clinico-pathological classification of neuroendocrine tumors of the gastroenteropancreatic tract.” QJ Nucl Med 44: 13-21.

Sanders, R. and H. Axtel (1964). “Carcinoids of the gastrointestinal tract.” Surg Gynecol Obstet 11: 369-80.

Schmutte, C. and P. A. Jones (1998). “Involvement of DNA methylation in human carcinogenesis.” Biol Chem 379 (4-5): 377-88.

Schutte, M., R. H. Hruban, et al. (1996). “DPC4 gene in various tumor types.” Cancer Res 56 (11): 2527-30.

Sjokvist, A., I. Brunsson, et al. (1993). “On the involvement of tachykinin neurons in the secretory nervous reflex elicited by cholera toxin in the small intestine.” Acta Physiol Skand 148: 387-92.

Skogseid, B. (2001). “Nonsurgical treatment of advanced malignant neuroendocrine pancreatic tumors and midgut carcinoids.” World J Surg 25: 700-703.

Skogseid, B., B. Eriksson, et al. (1991). “Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds.” J Clin Endocrinol Metab 73 (2): 281-7.


[page 46↓]

Skogseid, B., J. Rastad, et al. (1995). “Adrenal lesions in multiple endocrine neoplasia type 1.” Surgery 118: 1077-82.

Smith, J. R., J. D. Carpten, et al. (1995). “Approach to genotyping errors caused by nontemplated nucleotide addition by Taq DNA polymerase.” Genome Res 5 (3): 312-7.

Stacpoole, P. W. (1981). “The glucagonoma syndrome: clinical features, diagnosis, and treatment.” Endocr Rev 2 (3): 347-61.

Stridsberg, M., K. Oberg, et al. (1995). “Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours.” J Endocrinol 144 (1): 49-59.

Strodel, W. E., G. Talpos, et al. (1983). “Surgical therapy for small-bowel carcinoid tumors.” Arch Surg 118 (4): 391-7.

Sun, Y., A. Hildesheim, et al. (1995). “No point mutation but decreased expression of the p16/MTS1 tumor suppressor gene in nasopharyngeal carcinomas.” Oncogene 10: 785-8.

Takagi, Y., H. Kohmura, et al. (1996). “Somatic alterations of the DPC4 gene in human colorectal cancers in vivo [see comments].” Gastroenterology 111 (5): 1369-72.

Tanaka, C., T. Kimura, et al. (1998). “Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas [see comments].” J Clin Endocrinol Metab 83 (8): 2631-4.

Thakker, R. V., P. Bouloux, et al. (1989). “Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11.” N Engl J Med 321 (4): 218-24.

The European Consortium on MEN1. (1997). “Identification of the multiple endocrine neoplasia type 1 (MEN1) gene.The European Consortium on MEN 1.” Hum Mol Genet 6: 1177-83.

Thompson, G. B., J. A. van Heerden, et al. (1985). “Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis.” Surgery 98 (6): 1054-63.

Tiensuu Janson, E., J. Westlin, et al. (1994). “(111IN-DTPA-D-Phe) octreotide scintigraphy in patients with carcinoid tumours:the predictive value for somatostatin analogue treatment.” Eur J Endocrinol 131: 577-81.

Tiensuu Janson, E. M. and K. E. Oberg (1996). “Carcinoid tumours.” Baillieres Clin Gastroenterol 10 (4): 589-601.

Toliat, M. R., W. Berger, et al. (1997).Mutations in the MEN I gene in sporadic neuroendocrine tumours of gastroenteropancreatic system [letter].” Lancet 350 (9086): 1223.

Uchida, K., M. Nagatake, et al. (1996). “Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers.” Cancer Res 56 (24): 5583-5.

Van Hazel, G., J. Rubin, et al. (1983). “Treatment of metastatic carcinoid tumor with dactinomycin or dacarbazine.” Cancer Treat Rep 67: 583-585.

Vogelstein, B. and K. Kinzler (1993). “The multistep nature of cancer.” Trends genet 9: 138-41.

Wang, E. H., S. A. Ebrahimi, et al. (1998). “Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.” Cancer Res 58 (19): 4417-20.


[page 47↓]

Weckstrom, P., A. Hedrum, et al. (1996). “Midgut Carcinoids and Solid Carcinomas of the Intestine:Differences in Endocrine Markers and p53 Mutations.” Endocrine pathology 7: 273-279.

Weinberg, R. A. (1991). “Tumor suppressor genes.” Science 254 (5035): 1138-46.

Weitzman, J. B. and M. Yaniv (1999). “Rebuilding the road to cancer [news; comment].” Nature 400 (6743): 401-2.

Wermer, P. (1963). “Endocrine adenomatosis and peptic ulcer in a large kindred:inherited mutiple tumors and mosaic pleiotropism in man.” Am J Med 35: 205-12.

Wessels, F. J. and S. R. Schell (2001). “Radiofrequency Ablation Treatment of Refractory Carcinoid Hepatic Metastases.” J Surg Res 95: 8-12.

Wilander, E. and L. Grimelius (1993). “Identification, characterization and classification of endocrine tumours.” Zentralbl Pathol 139 (2): 95-100.

Wilander, E., M. Lundqvist, et al. (1989). “Gastrointestinal carcinoid tumours. Histogenetic, histochemical, immunohistochemical, clinical and therapeutic aspects.” Prog Histochem Cytochem 19 (2): 1-88.

Wilentz, R. E., G. H. Su, et al. (2000). “Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.” Am J Pathol 156 (1): 37-43.

Williams, E. and J. Azzopardi (1960). “Tumours of the lung and the carcinoid syndrome.” Thorax 15: 30-36.

Williams, E. and M. Sandler (1963). “The classification of carcinoid tumors.” Lancet 1 : 238.

Younes, N., N. Fulton, et al. (1997). “The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors.” Cancer 79 (9): 1804-8.

Zhao, J., R. R. de Krijger, et al. (2000). “Genomic Alterations in Well-Differentiated Gastrointestinal and Bronchial Neuroendocrine Tumors (Carcinoids).” Am J Pathol 157: 1431-38.

Zhuang, Z., A. O. Vortmeyer, et al. (1997). “Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas.” Cancer Res 57 (21): 4682-6.

Zollinger, R. M., E. C. Ellison, et al. (1980). “Primary peptic ulcerations of the jejunum associated with islet cell tumors. Twenty-five-year appraisal.” Ann Surg 192 (3): 422-30.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML generated:
19.07.2004